Thomas Martin, MD, University of California San Francisco

home / authors / thomas-martin,-md,-university-of-california-san-francisco

Articles

Expert on MM

Isatuximab Plus Carfilzomib and Dexamethasone in Relapsed Multiple Myeloma Patients With High-Risk Cytogenetics: IKEMA Subgroup Analysis

Thomas Martin, MD, University of California San Francisco
January 25th 2023

Expert hematologist-oncologist Thomas G. Martin, MD, shares data from the IKEMA subgroup analysis in patients with relapsed multiple myeloma treated with isatuximab, carfilzomib, and dexamethasone.

Read More

The Future of Multiple Myeloma

The Future of Multiple Myeloma

Thomas Martin, MD, University of California San Francisco;Yvonne Efebera, MD, Ohio State University Comprehensive Cancer Center
August 10th 2020

Read More

Targeted Treatment Options in Multiple Myeloma

Targeted Treatment Options in Multiple Myeloma

Thomas Martin, MD, University of California San Francisco;Yvonne Efebera, MD, Ohio State University Comprehensive Cancer Center
August 10th 2020

Read More

Trials in Relapsed/Refractory Multiple Myeloma

Trials in Relapsed/Refractory Multiple Myeloma

Thomas Martin, MD, University of California San Francisco;Yvonne Efebera, MD, Ohio State University Comprehensive Cancer Center
August 10th 2020

Read More

Treatment Options in Relapsed/Refractory Multiple Myeloma

Treatment Options in Relapsed/Refractory Multiple Myeloma

Thomas Martin, MD, University of California San Francisco;Yvonne Efebera, MD, Ohio State University Comprehensive Cancer Center
August 10th 2020

Read More

Options for Transplant Ineligible Patients in Multiple Myeloma

Options for Transplant Ineligible Patients in Multiple Myeloma

Thomas Martin, MD, University of California San Francisco;Yvonne Efebera, MD, Ohio State University Comprehensive Cancer Center
August 10th 2020

Read More

Maintenance Therapy in Multiple Myeloma

Maintenance Therapy in Multiple Myeloma

Thomas Martin, MD, University of California San Francisco;Yvonne Efebera, MD, Ohio State University Comprehensive Cancer Center
August 10th 2020

Read More

The Role of Transplant in Multiple Myeloma

The Role of Transplant in Multiple Myeloma

Thomas Martin, MD, University of California San Francisco;Yvonne Efebera, MD, Ohio State University Comprehensive Cancer Center
August 10th 2020

Read More

Looking at GRIFFIN Trial Data

Looking at GRIFFIN Trial Data

Thomas Martin, MD, University of California San Francisco;Yvonne Efebera, MD, Ohio State University Comprehensive Cancer Center
August 10th 2020

Read More

A Look at the ENDURANCE Trial

A Look at the ENDURANCE Trial

Thomas Martin, MD, University of California San Francisco;Yvonne Efebera, MD, Ohio State University Comprehensive Cancer Center
August 10th 2020

Read More

Newly Diagnosed Multiple Myeloma

Newly Diagnosed Multiple Myeloma

Thomas Martin, MD, University of California San Francisco;Yvonne Efebera, MD, Ohio State University Comprehensive Cancer Center
August 10th 2020

Read More

Introduction to Multiple Myeloma

Introduction to Multiple Myeloma

Thomas Martin, MD, University of California San Francisco;Yvonne Efebera, MD, Ohio State University Comprehensive Cancer Center
August 10th 2020

Read More